Arabic Arabic English English French French German German
dark

Biosimilar drugs could generate $38.4 billion in savings over five years

Biosimilar drugs could drive down prices for expensive medicines used to treat illnesses such as cancer and rheumatoid arthritis, with savings estimated to be $38.4 billion or 5.9% of projected total U.S. spending on biologics from 2021 to 2025, according to a new RAND Corporation study. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Even symptom-free, people with Omicron are much more likely to spread COVID, say studies

Next Post

Are you Britain’s next super-matcher? You can take a test to find out

Related Posts
Total
0
Share